2m 2m 2m 2m 2m 2m 2m
Moleculin Btech (MBRX)
NASDAQ
$5.70-$0.61 (-9.67%)
Price as of Oct 22, 2026 7:30 PM EDT- $128.6MMarket Cap
- -97.17%1-Year Change
- BiotechnologyIndustry
Moleculin Btech (MBRX)
$5.70-$0.61 (-9.67%)
MBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.31 | ||
Change | +$0.12 (+1.94%) | ||
Open | $6.00 | ||
High | $6.58 | ||
Low | $6.00 | ||
Previous Close | $6.19 | ||
Volume | 41,996 | ||
30-Day Average Volume | 60,147 | ||
1-Week Change | -23.24% | ||
1-Month Change | -39.35% | ||
1-Year Change | -97.17% | ||
3-Year Change | -99.86% | ||
5-Year Change | -99.97% | ||
Fundamentals | |||
Shares Outstanding | 20.4M | ||
Total Assets | $21.1M | ||
Market Cap | $128.6M | ||
Enterprise Value | $121.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$7.6M | ||
Free Cash Flow | -$6.7M | ||
EBIT | -$7.6M | ||
EBITDA | -$7.5M | ||
Net Working Capital | -$590,000.00 | ||
EPS | -$28.00 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 11 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/20/2026 | ||
Earnings & Revenue